Skip to results
Modify your search
NARROW
1-20 of 17561
Journal Article
A review of cutaneous angiosarcoma: epidemiology, diagnosis, prognosis, and treatment options Get access
Japanese Journal of Clinical Oncology, hyaf071, https://doi.org/10.1093/jjco/hyaf071
Published: 17 May 2025
Image
Clinical presentation of cutaneous angiosarcoma. (a) A well-demarcated lesi... Get access
Published: 17 May 2025
Figure 1
Clinical presentation of cutaneous angiosarcoma. (a) A well-demarcated lesion on the forehead of an elderly patient, resembling a bruise. The lesion shows relatively clear borders. (b) A plaque on the forehead. The central area is raised and tumorous, while the periphery has indistinct borders. (c)
Image
Surgical planning for a cutaneous angiosarcoma lesion. Get access
Published: 17 May 2025
Figure 2
Surgical planning for a cutaneous angiosarcoma lesion.
Image
Histopathological features of cutaneous angiosarcoma showing proliferation ... Get access
Published: 17 May 2025
Figure 3
Histopathological features of cutaneous angiosarcoma showing proliferation of atypical endothelial cells forming irregular vascular channels with areas of solid growth pattern.
Journal Article
Recurrence risk following rectal cancer surgery: a survival analysis of key predictors Get access
Japanese Journal of Clinical Oncology, hyaf080, https://doi.org/10.1093/jjco/hyaf080
Published: 16 May 2025
Journal Article
A randomized, placebo-controlled phase III trial of an autologous, formalin-fixed tumor vaccine for newly diagnosed glioblastoma: trial protocol Get access
Japanese Journal of Clinical Oncology, hyaf078, https://doi.org/10.1093/jjco/hyaf078
Published: 16 May 2025
Image
Schoenfeld residuals plot assessing the proportional hazards assumption. Al... Get access
Published: 16 May 2025
Figure 2
Schoenfeld residuals plot assessing the proportional hazards assumption. All P -values ˃0.05 suggest that the proportional hazards assumption holds for the corresponding variables, indicating that the effect of these variables on the hazard remains consistent over time. ASA, American Society of Ane
Image
Design of Cellm-001 clinical trial for patients with newly diagnosed GBM. ... Get access
Published: 16 May 2025
Figure 2
Design of Cellm-001 clinical trial for patients with newly diagnosed GBM. Intradermal injections of Cellm-001 before (one course) and after (two courses) TMZ-CRT are performed for each treatment course. Two injections of Cellm-001 or placebo in the first course are given ~3–4 weeks after surgery an
Image
Schematic process of Cellm-001 injection from gross total resection of GBM.... Get access
Published: 16 May 2025
Figure 1
Schematic process of Cellm-001 injection from gross total resection of GBM. An AFTV is manufactured from the patient's own GBM tissue made from the resected tumor, a process invented in collaboration with RIKEN. Cellm-001 is an autologous brain tumor immunostimulant equivalent to AFTV that complies
Image
A patient with multiple head and neck paragangliomas 46-year-old male patie... Get access
Published: 16 May 2025
Figure 1
A patient with multiple head and neck paragangliomas 46-year-old male patient with right vagal paraganglioma, right carotid body tumor and left carotid body tumor. (a and b) axial view of the contrast-enhanced CT image; (c) coronal view of the 18F-fluorodeoxyglucose-positron emission tomography (FDG
Journal Article
Carotid body tumors—epidemiology and surgical resection Get access
Japanese Journal of Clinical Oncology, hyaf074, https://doi.org/10.1093/jjco/hyaf074
Published: 16 May 2025
Image
Heatmap of pairwise correlations among study variables. The plot visualizes... Get access
Published: 16 May 2025
Figure 1
Heatmap of pairwise correlations among study variables. The plot visualizes the strength and direction of correlations, with darker colors indicating stronger correlations. To avoid multicollinearity, variables with high correlations (≥0.50) were further assessed, and one variable from each pair was
Image
Forest plot of HRs for study variables in the cox proportional hazards mode... Get access
Published: 16 May 2025
Figure 3
Forest plot of HRs for study variables in the cox proportional hazards model. Each horizontal line represents the 95% confidence interval for the HR, while the square markers indicate the point estimate of the HR for each variable. A HR >1 indicates an increased risk of recurrence, whereas a HR &
Image
Kaplan–Meier curves of cumulative hazard for patient categories. P... Get access
Published: 16 May 2025
Figure 4
Kaplan–Meier curves of cumulative hazard for patient categories. P -values indicate differences in cumulative hazards between groups as determined by the log-rank test. Age was considered a categorical variable (<65, and ≥65 years). pN, pathologic node stage; HLN, harvested lymph nodes.
Image
The flowchart of the choice of treatment of carotid body tumor. Get access
Published: 16 May 2025
Figure 2
The flowchart of the choice of treatment of carotid body tumor.
Image
General condition and degree of symptom distress in each palliative care ph... Get access
Published: 08 May 2025
Figure 1
General condition and degree of symptom distress in each palliative care phase. Note: PCPSS – Palliative care problem severity scale; AKPS – Australian modified Karnofsky performance status.
Image
HE and Immunohistochemical staining of PEComa (A) PEComas shows a nested ar... Get access
Published: 08 May 2025
Figure 1
HE and Immunohistochemical staining of PEComa (A) PEComas shows a nested architecture, comprising epithelioid cells with abundant granular eosinophilic or clear cytoplasm, round nuclei, and small nucleoli. Nests or trabeculae are surrounded by thin-walled capillary vessels (haematoxylin and eosin st
Journal Article
PEComa—its clinical features, histopathology, and current therapy Get access
Japanese Journal of Clinical Oncology, hyaf056, https://doi.org/10.1093/jjco/hyaf056
Published: 08 May 2025
Journal Article
Reliability and validity of the Japanese version of the palliative care phase in palliative care facilities Get access
Japanese Journal of Clinical Oncology, hyaf076, https://doi.org/10.1093/jjco/hyaf076
Published: 08 May 2025
Journal Article
Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational study Get access
Japanese Journal of Clinical Oncology, hyaf073, https://doi.org/10.1093/jjco/hyaf073
Published: 07 May 2025
